Topical bromfenac effective in improving vision in CME patients
According to this paper:
Administering topical Xibrom (bromfenac ophthalmic solution 0.09%, Ista Pharmaceuticals) twice daily is as effective as diclofenac sodium and ketorolac tromethamine for the treatment of acute pseudophakic CME after uncomplicated phacoemulsification and posterior chamber IOL implantation.
According to this paper:
Administering topical Xibrom (bromfenac ophthalmic solution 0.09%, Ista Pharmaceuticals) twice daily is as effective as diclofenac sodium and ketorolac tromethamine for the treatment of acute pseudophakic CME after uncomplicated phacoemulsification and posterior chamber IOL implantation.
No comments:
Post a Comment
Leave a Comment or Question: